With confusion surrounding the meaning of “savings” with regard to ACO programs, authors writing in Health Affairs outlined 3 different types of savings.
The Accountable Care Organization (ACO) program in Medicare is much-debated, with its success and viability as a means to curb healthcare spending growth being questioned.
The ACO program serves as the CMS' most notable population-based payment model. ACOs are formed by groups of healthcare entities that come together and take accountability for the spending and quality of care for their Medicare patients.
With the release of a report on the savings resulting from ACOs in the Medicare Shared Savings Program, the debate has been drawn back into the spotlight. According to an article published by Health Affairs, clarity on the program’s effectiveness requires addressing conceptual and semantic questions about the meaning of “savings.”
The authors of the article, including The American Journal of Managed Care® co-Editor-in-Chief Michael Chernew, PhD, have previously conluded savings must be assessed against a reasonable estimate of what the spending on ACO-attributed beneficiaries would have been without the ACO program. With confusion surrounding the meaning of “savings” in regard to the program, the authors outlined 3 different types of “savings.”
While savings might be small at first, evidence has shown that the longer a beneficiary is attributed to the ACO, the more savings are generated. With some questioning the ACO program, there are multiple reasons for continuing it.
ACOs allow providers to benefit financially because they generate efficiencies by giving providers a way to withstand fee cuts while providing better quality care for their patients. ACOs also generate savings over time, allowing payers to develop a successful payment model. Lastly, beneficiaries benefit from ACOs in the form of lower premiums and improved quality of care.
While the program will present challenges, this is seen in any strategy to reduce spending.
“A voluntary ACO program seems to offer a conceptually appealing way to give providers control over spending,” concluded the authors. “Given that early results show both utilization savings and payer savings—albeit modest, but growing—working to improve the model seems wise.”
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs
December 5th 2023Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.
Read More